Thermo Fisher Scientific and Hamilton Partner to Offer Storage Solutions
|
By LabMedica International staff writers Posted on 09 Nov 2016 |

Image: The Decapper 500 and 550 systems are designed for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories (Photo courtesy of Business Wire).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) and Hamilton Storage (Reno, NV, USA) have entered into a partnership to offer the fully automated Thermo Scientific Decapper 500 and 550 Series tube capping systems for researchers seeking to streamline their sample storage processes.
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Latest Industry News
- CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
- Thermo Fisher Scientific to Sell Microbiology Business to Astorg
- Collaboration Expands Access to Rapid Metagenomic Diagnostics for Complex Infections
- Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID
- QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition
- QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026
- Roche Affiliate Expands MRD Portfolio with SAGA Acquisition
- Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring
- Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections
- Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test
- GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR
- Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
- Takara Bio USA and Hamilton Partner to Automate NGS Library Preparation
- Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
- Integrated DNA Technologies Expands into Clinical Diagnostics
- Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
Channels
Clinical Chemistry
view channel
Blood Test Detects Testicular Cancer Missed by Standard Markers
Testicular cancer most often affects adolescents and young adults and is highly treatable when found early. Diagnosis can be difficult when tumors do not produce sufficient levels of standard blood-based... Read more
Routine Blood Tests Identify Biomarkers Linked to PTSD
Post-traumatic stress disorder (PTSD) is associated with a range of chronic physical health conditions and affects multiple organ systems. Clinical laboratories routinely measure blood analytes that reflect... Read moreMolecular Diagnostics
view channel
Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions
Cardiovascular disease is the leading cause of death worldwide, yet many at‑risk individuals are overlooked by traditional calculators. Tools that weigh age, sex, blood pressure, and cholesterol can miss... Read moreRoutine Genetic Marker May Help Guide Targeted Therapy in Acute Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer with widely variable treatment outcomes between patients. Choosing which individuals will benefit from targeted agents remains difficult, limiting... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection
Accurate laboratory diagnosis of early Lyme disease remains challenging because serologic responses may be limited soon after infection. Missed detection at this stage can delay evaluation and management... Read more
Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target
Immune aging undermines host defense and contributes to multiple age-related diseases, yet its heterogeneity complicates measurement and intervention. Clinical laboratories increasingly seek objective... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment
PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Interpretable AI Reveals Hidden Cellular Features from Microscopy Images
Microscopy images contain rich clues about cell health, but many disease-relevant morphological differences are too subtle to see and difficult to quantify consistently. Artificial intelligence (AI) has... Read moreTechnology
view channel
Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
Risk stratification for breast cancer remains imprecise, as population-based models and breast density can over- or underestimate individual risk, potentially leading to over- or under-screening.... Read more







